Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a novel sepsis prognosis model and analysis of possible drug application prospects: Based on scRNA-seq and RNA-seq data. | Front Immunol | 2022 | 36389695 | PubTator, text mining | PubMed |
| A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study. | Front Med (Lausanne) | 2022 | 36388933 | PubTator, text mining | PubMed |
| Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells. | Cell Rep Med | 2022 | 36384102 | PubTator, text mining | PubMed |
| Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents. | Signal Transduct Target Ther | 2022 | 36379915 | PubTator, text mining | PubMed |
| Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. | Cancer Cell | 2022 | 36379208 | PubTator, text mining | PubMed |
| Comprehensive characterization of costimulatory molecule gene for diagnosis, prognosis and recognition of immune microenvironment features in sepsis. | Clin Immunol | 2022 | 36368641 | PubTator, text mining | PubMed |
| High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. | Cancer Cell | 2022 | 36368318 | PubTator, text mining | PubMed |
| Immunology of Oral Squamous Cell Carcinoma-A Comprehensive Insight with Recent Concepts. | Life (Basel) | 2022 | 36362963 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor: What Is in a Name? | Cancers (Basel) | 2022 | 36358688 | PubTator, text mining | PubMed |
| Indicators of optimal diabetes care and burden of diabetes complications in Africa: a systematic review and meta-analysis. | BMJ Open | 2022 | 36351737 | PubTator, text mining | PubMed |
| GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome. | Nat Commun | 2022 | 36347862 | PubTator, text mining | PubMed |
| A Novel Multi-Epitope Edible Vaccine Candidate for Newcastle Disease Virus: In Silico Approach. | Iran J Biotechnol | 2022 | 36337069 | PubTator, text mining | PubMed |
| Notch activation during early mesoderm induction modulates emergence of the T/NK cell lineage from human iPSCs. | Stem Cell Reports | 2022 | 36332629 | PubTator, text mining | PubMed |
| Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy. | Front Med (Lausanne) | 2022 | 36313997 | PubTator, text mining | PubMed |
| Triptolide increases resistance to bile duct ligation-induced liver injury and fibrosis in mice by inhibiting RELB. | Front Nutr | 2022 | 36313114 | PubTator, text mining | PubMed |
| Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2. | Vaccines (Basel) | 2022 | 36298624 | PubTator, text mining | PubMed |
| Correlations between Cytokine Levels, Liver Function Markers, and Neuropilin-1 Expression in Patients with COVID-19. | Vaccines (Basel) | 2022 | 36298501 | PubTator, text mining | PubMed |
| IL-2 and IL-1β Patient Immune Responses Are Critical Factors in SARS-CoV-2 Infection Outcomes. | J Pers Med | 2022 | 36294868 | PubTator, text mining | PubMed |
| Single-Cell Analysis to Better Understand the Mechanisms Involved in MS. | Int J Mol Sci | 2022 | 36292995 | PubTator, text mining | PubMed |
| NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. | Cancers (Basel) | 2022 | 36291952 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=21